Aster DM Healthcare
An Indian healthcare group operating hospitals, clinics, pharmacies, diagnostic centres, and medical education institutions.
Last updated August 21, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Aster DM Healthcare Limited is an Indian healthcare company whose principal operations are based in India following the separation of its Indian and Gulf Cooperation Council businesses in 2024. Founded by physician Azad Moopen in 1987, the organisation began as a single-doctor clinic and developed into an integrated healthcare network spanning hospitals, outpatient clinics, pharmacies, diagnostic services, medical education, and professional training. The company's Indian presence became formal and substantial in 2001 through the Malabar Institute of Medical Sciences in Kozhikode, Kerala. Over subsequent years, Aster expanded in southern India through new hospital construction, acquisitions, and the conversion of existing facilities into Aster-branded institutions. Important additions included Aster Medcity in Kochi, Aster CMI Hospital in Bengaluru, the DM Wayanad Institute of Medical Sciences, Dr. Ramesh Hospitals in Andhra Pradesh, Aster MIMS Kannur, Aster RV Hospital, Aster Women's and Children's Hospital in Kottakkal, and Aster Whitefield in Bengaluru. The group also developed supporting businesses in retail pharmacy and diagnostics, allowing it to serve patients across the care pathway rather than relying exclusively on inpatient services. Aster Medcity in Kochi is the group's major quaternary-care facility in India. Other hospital operations provide multispecialty and specialty care, while Aster Labs offers laboratory and diagnostic testing through a central laboratory, satellite laboratories, and patient service centres. Aster Pharmacy extends the brand into medicine retail, and Dr. Moopen's Medical College and Aster Health Academy support medical and healthcare education. Aster entered the public markets in 2018. It also attracted institutional investment from Olympus Capital Holdings Asia, which acquired a minority position in 2012 and made a further investment in 2014 before exiting in 2024. In November 2023, Aster announced a plan to separate its GCC and Indian businesses. The transaction received shareholder approval in January 2024 and was completed in April 2024. A consortium led by Fajr Capital acquired a majority stake in the GCC business, which began operating independently as Aster DM Healthcare FZC, while the Moopen family retained a minority stake and operational control in that business. The Indian listed company continued under Aster DM Healthcare Limited, with its registered and India-operational base in Bengaluru. The company announced a proposed combination with Quality Care India Ltd. in November 2024, intended to create Aster DM Quality Care Ltd. It also continued expanding its Indian hospital footprint, including a 264-bed Aster MIMS facility in Kasaragod, Kerala, and increased its holding in Dr. Ramesh Cardiac and Multispecialty Hospital Private Limited. Beyond commercial healthcare delivery, the wider Aster brand has promoted nursing recognition and professional development through the Aster Guardians Global Nursing Award, launched in 2022. Aster's positioning is built around integrated, branded care delivered through a network of hospitals, clinics, pharmacies, laboratories, and education institutions.
History
Aster DM Healthcare was established in 1987 by physician Azad Moopen, initially as a single-doctor clinic. The organisation gradually expanded its scope from individual medical consultation into a broader healthcare platform. Its development combined organic growth, hospital construction, acquisitions, pharmacy operations, diagnostic services, and healthcare education. Aster's formal Indian expansion began in 2001 with the Malabar Institute of Medical Sciences in Kozhikode, Kerala. The institution later became part of the Aster network and helped establish the group as a hospital operator in southern India. In 2012, Olympus Capital Holdings Asia invested approximately US$100 million for a minority stake, becoming Aster's largest external investor at that time. Olympus made an additional investment of approximately US$60 million in 2014 and ultimately exited in June 2024. The group strengthened its tertiary and quaternary-care capabilities with the opening of Aster Medcity in Kochi in 2014, on a large campus designed for advanced multispecialty treatment. In 2016, Aster acquired Kavery Medical Institute in Bengaluru and redeveloped it as Aster CMI Hospital. During the same year, it took over the DM Wayanad Institute of Medical Sciences and acquired a majority stake in Dr. Ramesh Hospitals in Andhra Pradesh. Sangamitra Hospitals joined the network in 2018. Aster completed an initial public offering in 2018, after which its shares were listed on Indian stock exchanges. The company continued to add hospitals and related facilities. Aster MIMS Kannur and Aster RV Hospital in Bengaluru were established in 2019. In 2021, the group opened a Kottakkal hospital focused on women and children. Aster Whitefield in Bengaluru followed in 2023. Alongside hospitals, the company developed Aster Pharmacy, Aster Labs, and education platforms including Dr. Moopen's Medical College and Aster Health Academy. A major structural change began in November 2023, when Aster announced the proposed separation of its India and GCC operations. Shareholders approved the plan in January 2024, and the transaction closed in April 2024. A consortium led by Fajr Capital acquired 65% of the GCC business. That business became Aster DM Healthcare FZC and continued trading through the Aster Hospitals & Clinics brand in the UAE, Oman, and Bahrain. The Moopen family retained 35% of the GCC company and operational control, while continuing to hold a substantial stake in the Indian listed business. The transaction involved Affinity Holdings receiving US$907.6 million, according to the referenced account of the separation. After the separation, Aster DM Healthcare Limited's principal business became its Indian healthcare network, with Bengaluru serving as the registered base and headquarters for Indian operations. In November 2024, the company announced a proposed merger with Quality Care India Ltd. to form Aster DM Quality Care Ltd. Expansion continued in 2025 through new facilities and a higher ownership position in Dr. Ramesh Cardiac and Multispecialty Hospital Private Limited. The Aster brand also maintained a public-facing role in professional recognition through the Aster Guardians Global Nursing Award, established in 2022 for nurses contributing to patient care, leadership, education, community service, and healthcare innovation.
- 2025
Further Indian expansion
[1]Aster opens a 264-bed Aster MIMS hospital in Kasaragod and increases its holding in Dr. Ramesh Cardiac and Multispecialty Hospital Private Limited.
- 2024
India and GCC businesses separate
[1]Shareholders approve the separation and the transaction is completed, with Fajr Capital leading the acquisition of a 65% stake in the GCC business.
- 2024
Quality Care India combination is announced
[1]Aster announces a proposed merger with Quality Care India Ltd.
- 2023
Aster Whitefield opens and business separation is announced
[1]The group opens Aster Whitefield in Bengaluru and announces plans to separate its India and GCC businesses.
- 2022
Aster Guardians Global Nursing Award is established
[1]Aster launches an international award recognising nursing excellence and innovation.
- 2021
Women’s and children’s hospital opens in Kottakkal
[1]Aster opens a Kottakkal facility focused on women’s and children’s healthcare.
- 2019
New hospitals added in Kannur and Bengaluru
[1]Aster MIMS Kannur and Aster RV Hospital in Bengaluru join the network.
- 2018
Initial public offering
[1]Aster launches an IPO and its shares are subsequently listed on Indian stock exchanges.
- 2016
Expansion through Bengaluru and Andhra Pradesh acquisitions
[1]Aster acquires Kavery Medical Institute, later redeveloped as Aster CMI Hospital, takes over DM Wayanad Institute of Medical Sciences, and acquires a majority stake in Dr. Ramesh Hospitals.
- 2014
Aster Medcity opens in Kochi
[1]The group opens a major advanced-care hospital campus in Kochi, Kerala.
Products and positioning
An integrated, patient-centred healthcare network combining hospitals, ambulatory care, diagnostics, pharmacies, and healthcare education.
Hospital services
Aster Hospitals
Aster's hospital network provides multispecialty, tertiary, and quaternary healthcare. Facilities offer combinations of emergency care, surgery, cardiology, oncology, neurology, orthopaedics, women's and children's services, transplantation, intensive care, and other specialist departments. The network includes large destination hospitals such as Aster Medcity as well as regional hospitals serving local communities.
Quaternary-care hospital · 2014
Aster Medcity
Aster Medcity is the group's major advanced-care hospital campus in Kochi, Kerala. Developed on a large campus, it functions as a comprehensive quaternary-care centre with multiple clinical specialties, complex treatment capabilities, diagnostic infrastructure, and supporting patient services.
Multispecialty hospital · 2016
Aster CMI Hospital
Aster CMI Hospital in Bengaluru was created through the redevelopment of Kavery Medical Institute after its acquisition by Aster. It is part of the group's Bengaluru hospital network and provides advanced multispecialty medical and surgical services.
Pharmacy retail · 1989
Aster Pharmacy
Aster Pharmacy is the group's branded pharmacy business. Established in 1989, it operates retail outlets that dispense prescription medicines and provide access to health-related products connected with the wider Aster care network.
Diagnostics
Aster Labs
Aster Labs, formerly known as Aster Diagnostic Centre, provides laboratory and diagnostic testing. Its Indian operations include a Bengaluru laboratory, satellite laboratories, and patient service centres across several states, supporting both routine testing and hospital-linked diagnostics.
Medical education
Dr. Moopen's Medical College
Dr. Moopen's Medical College in Wayanad, Kerala, provides medical education and related training. Its programmes include undergraduate and postgraduate medical education as well as nursing and pharmacy instruction.
Healthcare training
Aster Health Academy
Aster Health Academy is the group's professional education and training initiative. It supports the development of healthcare workers and extends the Aster ecosystem beyond direct patient treatment.
Marketing campaigns
- 2024Aster Guardians Global Nursing Award third edition
Global · India
The third edition took place in Bengaluru in November 2024. The programme attracted more than 78,000 applicants from over 200 countries and used an independent jury, with Ernst & Young LLP as external evaluation partner.
Outcome. Scaled the programme into a large international nursing recognition initiative.
- 2023Aster Guardians Global Nursing Award second edition
Global · United Kingdom
The second edition was held in London in May 2023, with Margaret Helen Shepherd of the United Kingdom receiving the award.
Outcome. Expanded the award's international profile.
- 2022Aster Guardians Global Nursing Award
Global
Aster established an international award to recognise nurses for patient care, leadership, education, community service, and healthcare innovation. The inaugural award was presented in Dubai in May 2022 to Kenya's Anna Qabale Duba.
Outcome. Created an annual international nursing recognition platform.
Brand decisions
2025
Expansion of the hospital network and higher Dr. Ramesh stakeGeneration changeBackground
Aster continued building regional capacity and increasing ownership in an existing hospital affiliate.
Action taken
The company opened a 264-bed Aster MIMS hospital in Kasaragod, Kerala, and increased its stake in Dr. Ramesh Cardiac and Multispecialty Hospital Private Limited to 70.49%.
Aftermath
The moves expanded Aster's Indian hospital presence and increased its economic interest in the Dr. Ramesh operation.
2024
Separation of India and GCC operationsStrategyBackground
Aster operated healthcare businesses across India and the Gulf Cooperation Council and announced that the two regional businesses would be separated.
Action taken
Following shareholder approval, a Fajr Capital-led consortium acquired a 65% stake in the GCC business. The GCC company became Aster DM Healthcare FZC, while the Indian listed company continued as Aster DM Healthcare Limited.
Aftermath
The Indian business became operationally centred in Bengaluru, while the GCC business operated independently across the UAE, Oman, and Bahrain. The Moopen family retained 35% of the GCC business and operational control.
Transaction proceeds received by Affinity Holdings. US$907.6 million (April 2024 completion of the India–GCC separation)
2024
Proposed combination with Quality Care IndiaM&ABackground
Aster pursued further scale in India's hospital sector after the separation of its GCC and Indian businesses.
Action taken
Aster announced a proposed merger with Quality Care India Ltd. to form Aster DM Quality Care Ltd.
Aftermath
The referenced material does not establish the final completion status or post-merger operating structure.
2018
Public listing through an initial public offeringOtherBackground
Aster sought public-market access to support the development of its healthcare network.
Action taken
The company conducted an IPO and subsequently listed its shares on Indian stock exchanges.
Aftermath
Aster became a publicly traded Indian healthcare company.
Recent events
Aster DM Healthcare partners with Dr Reddy's to administer Sputnik V[3]
Reported:
Aster DM Healthcare said it had partnered with Dr Reddy's Laboratories to administer Sputnik V in a limited pilot soft launch, initially in Kochi, Kerala, and Kolhapur, Maharashtra.
Aster DM Healthcare signs partnership with Roche Diagnostics[4]
Reported:
Aster DM Healthcare signed a memorandum of understanding with Roche Diagnostics, making Roche Diagnostics its strategic partner across the UAE, Saudi Arabia, Qatar and Oman. The agreement includes antibody COVID-19 testing, digital solutions and automated laboratory solutions.
Aster DM Healthcare partners with Atal Innovation Mission[5]
Aster DM Healthcare and Atal Innovation Mission entered a strategic partnership to support innovation and entrepreneurship initiatives in India, including in digital health care.
Aster DM Healthcare agrees to invest in Alfaone Medicals[6]
Reported:
Aster DM Healthcare entered into a share subscription agreement to invest in 15.98% of Alfaone Medicals' equity for Rs 22.85 lakh. The deal was expected to be completed by 31 January 2021.
flydubai and Aster partner to offer PCR tests[7]
Reported:
flydubai said it partnered with Aster DM Healthcare to offer passengers COVID-19 PCR testing for Dh180 per test at participating Aster facilities in Dubai and the Northern Emirates.
- Unconfirmed
Aster hospitals receive six AHPI Awards[8]
Reported:
Five hospitals in the Aster DM Healthcare group received recognition at the AHPI Awards 2020. The report names awards received by Aster Medcity, Aster CMI Hospital, Aster MIMS Hospital, Medcare Women and Children Hospital, and Medcare Hospital.
Sources8 sources
- 1Aster DM Healthcareen.wikipedia.org
- 2Aster DM Healthcare official websiteasterdmhealthcare.com
- 3Aster DM Healthcare与Dr Reddy's合作接种Sputnik V疫苗thehindu.com
- 4Aster DM Healthcare与Roche Diagnostics签署合作协议gulfnews.com
- 5Aster DM Healthcare与Atal Innovation Mission建立合作biospectrumindia.com
- 6Aster DM Healthcare同意投资Alfaone Medicalsbusiness-standard.com
- 7flydubai与Aster合作提供PCR检测gulfnews.com
- 8Aster旗下医院获得六项AHPI奖项aninews.in
Cite this profile: Cite the canonical profile. /brand-wiki/aster-dm-healthcare · Editorial policy · How profiles are compiled